Similar Articles
1371 Detection of eukaryotic translation initiation factor 4E and its clinical significance in hepatocellular carcinoma
1372 Lamivudine treatment enabling right hepatectomy for hepatocellular carcinoma in decompensated cirrhosis
1373 Global hypomethylation in hepatocellular carcinoma and its relationship to aflatoxin B1 exposure
1374 Anti-tumor effect of 5-aza-2'-deoxycytidine by inhibiting telomerase activity in hepatocellular carcinoma cells
1375 Salvage liver transplantation in the treatment of hepatocellular carcinoma: A Meta-analysis
1376 Branched-chain amino acids to tyrosine ratio value as a potential prognostic factor for hepatocellular carcinoma
1377 Transactivation of the TIEG1 confers growth inhibition of transforming growth factor-β-susceptible hepatocellular carcinoma cells
1378 Aberrant methylation of SPARC in human hepatocellular carcinoma and its clinical implication
1379 Factors associated with the overall survival of elderly patients with hepatocellular carcinoma
1380 Is hepatic arterial infusion chemotherapy effective treatment for advanced hepatocellular carcinoma resistant to transarterial chemoembolization?
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA